CAR T cells show superiority over standard therapies for RRMM

被引：0

|

作者：

David Killock

机构：

[1] Nature Reviews Clinical Oncology,

来源：

Nature Reviews Clinical Oncology | 2023年 / 20卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：210 / 210

相关论文

共 50 条

[1] CAR T cells show superiority over standard therapies for RRMM
Killock, David
NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (04) : 210 - 210
[2] Combining CAR T cells effective in RRMM
Sidaway, Peter
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (06) : 360 - 360
[3] Combining CAR T cells effective in RRMM
Peter Sidaway
Nature Reviews Clinical Oncology, 2022, 19 : 360 - 360
[4] CAR T cells show activity
Romero, Diana
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (07) : 427 - 427
[5] CAR T cells show activity
Diana Romero
Nature Reviews Clinical Oncology, 2022, 19 : 427 - 427
[6] Allogeneic CAR T cells show promise
Sidaway, Peter
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (12) : 748 - 748
[7] CAR T cells show promise in mesothelioma
Killock, David
NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (09) : 541 - 541
[8] CAR T Cells Show Solid Progress
Roberts J.P.
Genetic Engineering and Biotechnology News, 2018, 38 (13): : 26 - 27
[9] CAR T cells show promise in mesothelioma
David Killock
Nature Reviews Clinical Oncology, 2021, 18 : 541 - 541
[10] Allogeneic CAR T cells show promise
Peter Sidaway
Nature Reviews Clinical Oncology, 2022, 19 : 748 - 748

← 1 2 3 4 5 →